LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES--(BUSINESS WIRE)---- $LFST #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company and its officers' possible violations of the federal securities laws. If you suffered a loss on your LifeStance investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, y

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)---- $LFST #CLASSACTION--Law Offices of Howard G. Smith continues its investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company and its officers' possible violations of federal securities laws. In June 2021, LifeStance completed its initial public offering (“IPO”), issuing 32.8 million shares at $18 per share. On August 11, 2021, LifeStance announced its second quarter 2021 financial results, reporting a net l

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

SCOTTSDALE, Ariz., Aug. 19, 2021 /PRNewswire/ --  LifeStance Health , (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, announced it now offers both virtual and in-person services in Maryland, Michigan, Minnesota, South Carolina and Wisconsin.

LifeStance Health Enters Maryland, Michigan, Minnesota, South Carolina And Wisconsin, Expanding Its National Footprint To 31 States

SCOTTSDALE, Ariz., Aug. 17, 2021 /PRNewswire/ -- LifeStance Health Foundation, an organization endowed by LifeStance Health  (NASDAQ: LFST), today announced it has donated $30,000 to the U.S. Olympic & Paralympic Foundation in support of athletes' mental health.

LifeStance Health Foundation Advances Its Mission To Improve Mental Health Access, Announces Latest Grantee

Atlanta, Georgia--(Newsfile Corp. - August 16, 2021) -  Holzer & Holzer, LLC is investigating whether LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST) complied with federal securities laws. On August 11, 2021, LifeStance, one of the largest providers of mental healthcare in the United States, announced financial results for the second quarter, reporting a $70 million net loss. LifeStance also provided disappointing estimates for third quarter, which was below analysts' consensus. During the...

SHAREHOLDER ALERT: Investigation of LifeStance Health Group, Inc. Announced by Holzer & Holzer, LLC

NEW YORK--(BUSINESS WIRE)---- $LFST--The law firm of Kirby McInerney LLP is investigating potential claims against LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST). The investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices. LifeStance is one of the nation's largest providers of virtual and in-person outpatient mental health care for children, adolescents, and adults experiencing a variety of menta

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against LifeStance Health Group, Inc.

Boston, Massachusetts--(Newsfile Corp. - August 12, 2021) - The Thornton Law Firm alerts investors that it is investigating LifeStance Health Group, Inc. (NASDAQ: LFST) for potential securities violations. Investors who currently own shares or options of LFST may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/LifeStance for more information. Investors may also email investors@tenlaw.com or call 617-531-3917. FOR MORE INFORMATION: www.tenlaw.com/cases/LifeStanceOn August 11, 2021, LifeStance Health Group released a disappointing financial...

Thornton Law Firm Announces Investigation Into LFST

SAN DIEGO, Aug. 12, 2021 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against LifeStance Health Group, Inc. (NASDAQ: LFST) ("LifeStance " or the "Company") for violations of federal securities laws. On Wednesday, August 11, 2021, LifeStance released its second quarter ended June 30, 2021, financial results, reporting a net loss of $70 million.

(LFST) Alert: Johnson Fistel Launches Investigation into LifeStance Health Group - Stock Price has Plummeted Since IPO; Investors Suffering Losses Encouraged to Contact the Firm

The mental health service provider surprised investors with heavy operating losses.

Why LifeStance Health Group Stock Is Crashing Today

LifeStance Health Group, Inc. (LFST) CEO Michael Lester on Q2 2021 Results - Earnings Call Transcript

SCOTTSDALE, Ariz., Aug. 11, 2021 /PRNewswire/ --  Second Quarter 2021 Highlights Revenue of $160.5 million increased $76.5 million or 91%1 compared to revenue of $38.6 million for the period from April 1, 2020 to May 14, 2020 (Predecessor) and $45.4 million for the period from April 13, 2020 to June 30, 2020 (Successor) Total clinicians of 3,975 up 94% year over year, including 674 net clinician adds in the second quarter Net loss was $70.0 million compared to net loss of $27.6 million for the period from April 1, 2020 to May 14, 2020 (Predecessor) and $4.3 million for the period from April 13, 2020 to June 30, 2020 (Successor) Adjusted EBITDA of $14.5 million increased $4.1 million or 39%1 compared to Adjusted EBITDA of $4.4 million for the period from April 1, 2020 to May 14, 2020 (Predecessor) and $6.0 million for the period from April 13, 2020 to June 30, 2020 (Successor) Successfully completed initial public offering (IPO) on the Nasdaq Global Select Market on June 10, 2021; net proceeds of $548.9 million used to retire debt and for general corporate purposes Established the LifeStance Health Foundation with initial endowment of $10.0 million; announced partnership with The Mental Health Coalition to help end the stigma around mental health conditions and committed $30,000 to the U.S. Olympic & Paralympic Foundation in support of athletes' mental health Initiating 2021 guidance: Revenue of $668 million to $678 million; Center Margin of $198 million to $208 million; Adjusted EBITDA of $47 million to $53 million LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced financial results for the second quarter ended June 30, 2021.

LifeStance Health Reports Second Quarter 2021 Results

SCOTTSDALE, Ariz. and NEW YORK, July 28, 2021 /PRNewswire/ -- LifeStance Health  (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced it has partnered with The Mental Health Coalition.

LifeStance Health And The Mental Health Coalition Partner To End Stigma Around Mental Health Conditions

SCOTTSDALE, Ariz., July 27, 2021 /PRNewswire/ -- LifeStance Health  (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced the LifeStance Health Foundation, an organization endowed by LifeStance Health, is donating $30,000 to the U.S. Olympic & Paralympic Foundation in support of athletes' mental health.

The LifeStance Health Foundation Donates To The U.S. Olympic & Paralympic Foundation In Support Of Athletes' Mental Health

SCOTTSDALE, Ariz., July 21, 2021 /PRNewswire/ -- LifeStance Health Group Inc., (NASDAQ: LFST) one of the nation's largest providers of outpatient mental health care, will issue its second quarter earnings release after the market closes on August 11, 2021.

LifeStance Health Announces Second Quarter 2021 Earnings Release

Acadia Healthcare

COMPASS Pathways

Intra-Cellular Therapies

Mind Medicine MindMed

Teladoc

One of the most devastating long-term impacts of the COVID-19 pandemic may be the toll it has taken on people's mental health. The next global health crisis may be related to mental health issues such as anxiety and depression, and companies that are focused on mental health could be well-positioned to capitalize on the opportunity.

Pandemic Fallout: 6 Mental Health Stocks To Watch

SCOTTSDALE, Ariz., June 22, 2021 /PRNewswire/ --  LifeStance Health, one of the nation's largest providers of outpatient mental health care, today launched its "No Face" campaign shot by iconic photographer Mark Seliger , which was developed to encourage candid conversations about mental health and reduce the stigma around seeking treatment.

LifeStance Health Launches "No Face" Campaign To Destigmatize Mental Health

SCOTTSDALE, Ariz., June 14, 2021 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance Health" or the "Company"), one of the nation's largest providers of outpatient mental health care, today announced the closing of its initial public offering of 40,000,000 shares of its common stock at a public offering price of $18.00 per share.

LifeStance Health Group, Inc. Announces Closing of Initial Public Offering

LifeStance is growing rapidly in a huge and underserved mental disorder market. Organic growth is very impressive, as the company appears to be steering towards break even results.

LifeStance Health Group: Strong Mental Disorder Play

Blue Safari Group Acquisition Corp

Kanzhun Ltd

1stdibs.com

Global Consumer Acquisition Corp

Janux Therapeutics

Logistics Innovation Technologies Corp

monday.com

Marqeta

TaskUS

Zeta Global Holdings Corp

Zhangmen Education

U.S. IPO Weekly Recap: Summer's First Wave Brings 10 IPOs

LifeStance Health plans to use part of its IPO proceeds to pay down debt, CEO Mike Lester said. The company aims to improve the mental health of consumers across the U.S.

LifeStance Health and Monday.com Stock Rise in First Day of Trading. What to Know.

Monday.com, LifeStance Health Group, and 1stdibs.com listed on the Nasdaq. Zeta Global Holdings picked the New York Stock Exchange.

Monday.com, 3 Other IPOs, Hit the Market

Monday.com, LifeStance Health Group, and 1stdibs.com are listed on the Nasdaq; Zeta Global Holdings picked the New York Stock Exchange.

4 Companies Begin Trading Today

SCOTTSDALE, Ariz., June 9, 2021 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance Health" or the "Company"), one of the nation's largest providers of outpatient mental health care, today announced the pricing of its initial public offering of 40,000,000 shares of its common stock at a public offering price of $18.00 per share.

News for LifeStance Health Group Stock (LFST)